Jennison Associates LLC Emergent Bio Solutions Inc. Transaction History

Jennison Associates LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$56.61 - $80.46 $9.2 Million - $13.1 Million	-162,550 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$86.23 - $125.19 $20 Million - $29 Million	-231,924 Reduced 58.79%	162,550 $15.1 Million
Q4 2020 Feb 05, 2021	SELL	$79.17 - $111.47 $4.61 Million - $6.48 Million	-58,174 Reduced 12.85%	394,474 $35.3 Million
Q3 2020 Nov 04, 2020	BUY	$81.91 - $134.94 $177,253 - $292,010	2,164 Added 0.48%	452,648 $46.8 Million
Q2 2020 Aug 06, 2020	SELL	$54.33 - $89.52 $4.41 Million - $7.27 Million	-81,250 Reduced 15.28%	450,484 $35.6 Million
Q1 2020 May 06, 2020	SELL	$49.34 - $68.76 $5.44 Million - $7.59 Million	-110,313 Reduced 17.18%	531,734 $30.8 Million
Q4 2019 Feb 07, 2020	BUY	$51.21 - $59.06 $3.07 Million - $3.54 Million	59,938 Added 10.3%	642,047 $34.6 Million
Q3 2019 Nov 08, 2019	BUY	$40.6 - $57.2 $811,512 - $1.14 Million	19,988 Added 3.56%	582,109 $30.4 Million
Q2 2019 Aug 06, 2019	BUY	$39.92 - $53.86 $14.9 Million - $20.1 Million	372,857 Added 197.0%	562,121 $0
Q1 2019 May 10, 2019	BUY	$48.23 - $66.16 $9.13 Million - $12.5 Million	189,264 New	189,264 $9.56 Million

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.